Skip to main content
Clinical Trials/NCT01506232
NCT01506232
Terminated
Not Applicable

Brain Activity Flow Patterns Analysis Using Evoked Response Potentials in Youth With ADHD, Bipolar Disorder, or Autism Spectrum Disorders: A Preliminary Study

Massachusetts General Hospital1 site in 1 country1 target enrollmentMarch 2011

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Attention Deficit Hyperactivity Disorder
Sponsor
Massachusetts General Hospital
Enrollment
1
Locations
1
Primary Endpoint
Agreement between clinical diagnoses and the results of brain activity flow pattern analysis (BAFPA).
Status
Terminated
Last Updated
last year

Overview

Brief Summary

The study aims to evaluate whether or not an EEG (a type of brain scan) is useful in diagnosing youth with either ADHD, BPD, ASD. Youth with ADHD, BPD, ASD, and healthy controls (without ADHD, BPD, and ASD) will undergo an EEG, and the results will be analyzed using brain activity flow pattern analysis (BAFPA). Twenty subjects with each disorder and twenty without any of the disorders under study (controls) will be evaluated. All subjects will be comprehensively assessed with structured diagnostic interviews and neuropsychological testing. All EEG analyses will be conducted under blind conditions. Conditional probability and receiver operating characteristic (ROC) analyses will examine the diagnostic utility of the EEG scan, using the clinical diagnosis of ASD as the gold standard.

Registry
clinicaltrials.gov
Start Date
March 2011
End Date
November 2012
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Gagan Joshi

Scientific Director, Pervasive Developmental Disorders Program, Clinical and Research Programs in Pediatric Psychopharmacology

Massachusetts General Hospital

Eligibility Criteria

Inclusion Criteria

  • Male or female participants between 6 and 17 years of age.
  • Right handedness.
  • Fulfills DSM-IV-TR diagnostic criteria for ADHD, bipolar disorder (BPD I, II, or NOS), or ASD (autistic disorder, Asperger's disorder, or PDD-NOS) as established by clinical diagnostic interview and supported by K-SADS-E module for respective diagnoses.
  • Subjects and their legal representative must have a level of understanding sufficient to communicate intelligently with the investigator and study coordinator, and to cooperate with all tests and examinations required by the protocol.
  • Subjects and their legal representative must be considered reliable.
  • Each subject and his/her authorized legal representative must understand the nature of the study. The subject's authorized legal representative must sign an informed consent document and the subject must sign an informed assent document.

Exclusion Criteria

  • Investigator and his/her immediate family; defined as the investigator's spouse, parent, child, grandparent, or grandchild.
  • I.Q. \< 85
  • History of active seizure disorder (as suggested by EEG suggestive of seizure activity and/or history of seizure in last 1 month)
  • Pregnant or nursing females.
  • Subjects with a medical condition that will either jeopardize subject safety or affect the scientific merit of the study, including:
  • Organic brain disorders
  • Uncorrected hypothyroidism or hyperthyroidism
  • Renal or hepatic impairment.
  • Clinically unstable psychiatric conditions or judged to be at serious suicidal risk
  • Current diagnosis of schizophrenia

Outcomes

Primary Outcomes

Agreement between clinical diagnoses and the results of brain activity flow pattern analysis (BAFPA).

Time Frame: Baseline

Subjects will undergo clinical diagnostic interviews and a comprehensive neuropsychological assessment, and then complete 1 EEG scan of approximately 1 hour. The results of the BAFPA will be compared to the results of the clinical diagnostic interviews.

Study Sites (1)

Loading locations...

Similar Trials